Two ideas under one name
“Biochip” is a loose label. It covers two related but different families of devices, and the history makes more sense once they are separated.
- Microarrays are flat surfaces, often a glass slide or a small silicon-based chip, dotted with thousands of tiny spots. Each spot holds a known piece of DNA, or sometimes protein. A sample is washed over the surface, and the spots that react show what the sample contains.
- Lab-on-a-chip devices use tiny channels, chambers and valves, usually a few tenths of a millimeter wide, to move and process very small volumes of liquid. They aim to shrink steps normally done on a laboratory bench onto a chip.
The word “chip” is borrowed from electronics. The comparison is partly literal, because some of the manufacturing methods were borrowed too, and partly marketing. Biochips are not computers, and most do not contain integrated circuits at all.
The idea behind DNA microarrays
DNA strands pair up in a predictable way. A strand will stick to its matching partner, a process called hybridization. This was well understood by the 1960s and was used in older lab methods, where researchers tested one gene at a time on membranes.
The step forward was doing thousands of tests at once on a single surface. In the early 1990s, a group around Stephen Fodor, working at the company Affymetrix, described building DNA sequences directly on a glass surface using light-directed chemistry borrowed from semiconductor photolithography. That technique, the same family of methods used to pattern silicon chips, let them place a huge number of different short DNA pieces in a tiny area. Their early work is often cited as the origin of the commercial “GeneChip” arrays.
A different approach appeared in the mid-1990s from the lab of Patrick Brown at Stanford University, where researchers used a robot to print or “spot” prepared DNA onto glass slides. A 1995 paper by Mark Schena, Brown and coworkers described measuring the activity of many genes at once this way. Spotting arrays were cheaper to make in a university lab, which helped the idea spread.
Both approaches were developed more or less in parallel, and credit for the field is shared among several groups. Hedging is wise here: different histories emphasize different people.
Why genomics gave them momentum
Microarrays arrived just as large-scale genome sequencing efforts were producing long lists of genes whose roles were unknown. A single array could show which genes were switched on in one kind of tissue compared with another. Researchers used them in the late 1990s and 2000s to study how cells respond to drugs, how tumors differ from healthy tissue, and how organisms develop.
This was research, not diagnosis. Early results were noisy and hard to compare between laboratories, and scientists spent years developing better statistical methods and quality controls. Over time, newer DNA sequencing methods took over many of the jobs that arrays once did, though arrays are still used for some tasks, such as scanning for known genetic variants.
The lab-on-a-chip branch
The second family grew from a different place: chemistry. In 1979, researchers at Stanford, led by S. C. Terry, described a miniature gas analysis system etched into a silicon wafer. It attracted limited attention at the time.
The concept returned around 1990, when Andreas Manz and colleagues, then at the Swiss company Ciba-Geigy, proposed what they called a “miniaturized total chemical analysis system.” The goal was to combine sampling, mixing, separation and detection in one tiny device. Microfabrication methods developed for electronics, along with later use of plastics and a soft, rubber-like material for making channels, made experiments cheaper.
The field that grew around these ideas is called microfluidics. It studies how liquids behave in channels that small, where flow is smooth and mixing happens slowly by diffusion rather than by turbulence. Some of its devices handle single cells or tiny droplets, and others run a quick test using a drop of blood.
What reached everyday use
Most people never see a biochip, but a few results have become familiar or influential.
- Research tools. Arrays and microfluidic cartridges are common in research laboratories and in some automated analyzers.
- Point-of-care testing. Some portable diagnostic cartridges use microfluidic principles to analyze a small sample outside a central lab. Many everyday tests, such as simple strips, work on related ideas but are not usually called biochips.
- Sequencing technology. Several DNA sequencing instruments rely on microfabricated surfaces, tiny wells or flow cells, which grew out of the same miniaturization mindset.
- Cell and organ models. Researchers have built small chips lined with living cells that imitate parts of organs. These are used in experiments and are not a replacement for clinical trials.
Promise versus reality
The early pitch for biochips was that a pocket-sized device could run a whole laboratory’s worth of tests on a drop of fluid. Parts of that have been achieved, but the full vision has been harder than expected. Real samples such as blood or saliva are messy. Sample preparation often still needs conventional equipment, so the “lab” on the chip is only partly there. Reliability, manufacturing cost and regulatory review also slow adoption.
The history of biochips shows how one tool crossed from electronics manufacturing into biology. It also shows a common technology pattern: an idea arrives with sweeping claims, researchers narrow it to the tasks it does well, and a cluster of more modest uses survives. Modern work often pairs microfluidics with new tools such as gene editing for experiments, with progress measured in carefully controlled studies rather than headlines. Related ideas also appear in diagnostic imaging and in the study of the double helix structure that made DNA matching so useful in the first place.